1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient :
In 1 g of cream; Retinoic acid
Methyl hydroxybenzoate Propyl hydroxybenzoate Butyl hydroxytoluene E321 Propylene glycol
3. PHARMACEUTICAL FORM
Light yellow homogeneous cream
4. CLINICAL FEATURES
4.1. Therapeutic indications 1.15 mg (15% ex-dose)
45.0 mg 45.0 mg 1.5 mg 0.5 mg 1.0 mg 200.0 mg
ACNELYSE is used in the treatment of acne vulgaris seen with comedones, papules and pustules.
4.2. Posology and method of application
Posology / application frequency and duration:
ACNELYSE is applied to the skin once a day at night.
With the application, there may be a temporary temperature and stinging sensation on the skin. If necessary, the dose to be tolerated by the patient can be adjusted by interrupting treatment or reducing the frequency of administration.
There may be an increase in inflammatory lesions in the first weeks of treatment. This is due to the effect of the drug on the lesions and does not require discontinuation of the drug.
Treatment results appear after 2-3 weeks, but more than 6 weeks may be required for full benefit.
The drug can be used less frequently after the lesions start to heal.
Method of Application :
Apply ACNELYSE with a fingertip gently on the skin of the lesion.
Patients using ACNELYSE can use cosmetics; however, the skin must be completely cleaned before treatment.